Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

European Pharmaceutical Review

MARCH 11, 2024

HIV treatment and prevention are at an inflection point after years of continuously improving the standard of care of once-daily oral medicines. Our industry is on the cusp of the next wave of medicines that will guide the coming decade of HIV care, making HIV a smaller part of people’s lives. 3 But that paradigm is rapidly changing.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98

European Pharmaceutical Review

JULY 27, 2023

Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. Despite these trials varying in design, they confirmed the feasibility and safety of the procedure. Frontiers in Pharmacology.

Pharmacology 98

Pharmacology Manufacturing Leads Patients 98

Pharmaceutical Representative Training

JANUARY 30, 2025

3 Together, these processes determine the drugs concentration in the bloodstream and tissues over time, directly impacting its effectiveness and safety. A highly effective drug (PD) may pose safety concerns if it accumulates due to slow metabolism or excretion (PK). Rang & Dale’s Pharmacology. 9th Edition. Goodman, L.

Pharmacology 52

Pharmacology Side effects Distribution Sales 52

Contrarian Sales Techniques

FEBRUARY 25, 2023

During my pharmacology class, I learned that there are no safe drugs, only safe patients. This highlights the importance of taking an individualized approach to medicine and considering a patient's unique medical history, current health status, and other relevant factors when prescribing medication.

Side effects 52

Side effects Medical sales reps Insurance Medical sales 52

Pharmaceutical Technology

FEBRUARY 8, 2023

Still, Blank suggested that companies enroll the patient population that is most likely to benefit, because early phase studies contain the most safety risks. Furthermore, due to smaller patient populations, rare disease trials are often smaller in size than other disease trials.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

Pharmaceutical Technology

SEPTEMBER 14, 2022

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.

Leads 40

Leads Marketing Pharmacology Retail 40

European Pharmaceutical Review

SEPTEMBER 22, 2023

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed. Andrea Pfeifer, PhD In 2003, Andrea Pfeifer co-founded AC Immune SA.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

Infuse Medical

DECEMBER 17, 2024

3D medical animation for healthcare breaks out these concepts into visually digestible bits whether you’re a surgeon outlining a difficult operation or a pharmaceutical company showing how a medicine operates at the cellular level. By incorporating 3D animation into your marketing efforts, you can: Boost product adoption.

Medical 130

Medical Healthcare Healthcare Education 130

European Pharmaceutical Review

JULY 25, 2024

This progress underscores the potential of gene therapy to revolutionise medicine by addressing the root causes of genetic disorders. Palframan received his BSc in pharmacology at King’s College London and his PhD in immunology at Imperial College London. What should the industry prioritise to advance the gene therapy field?

Pharmacology 52

Pharmacology Manufacturing Medicine Training 52

European Pharmaceutical Review

JULY 18, 2024

The potential to target more than one tumour antigen is interesting, as are the possible advantages for the patients receiving these investigational medicines. This covers nonclinical drug safety, translational and clinical pharmacology, drug metabolism and pharmacokinetics (DMPK) and pharmacometrics.

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

European Pharmaceutical Review

FEBRUARY 13, 2025

Oligonucleotide therapeutics (oligos), a promising class of drugs that can modulate gene expression or protein function, are reshaping modern medicine. Yet these innovations pose great challenges to bioanalytical techniques and safety evaluations. Safety of Antisense Oligonucleotide And Sirna-Based Therapeutics. Liu T, Altman R.

Safety 52

Safety Medicine Pharmacology Leads 52

Pharmaceutical Representative Training

JUNE 22, 2024

They must be familiar with the different national authorities; the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regulations that govern the pharmaceutical marketing and sales. This knowledge can include pharmacology, therapeutic areas, and data from clinical trials with different medications.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

European Pharmaceutical Review

JANUARY 13, 2025

We have programmes that investigate the types of medicines we produce and how we produce them, the energy we use (globally, 99 percent of our energy comes from renewable sources), and the practices of our entire global value chain. With our carbon-minimal inhaler programme, for instance, the investment we are making is significant.

Medicine 52

Medicine Pharmaceutical Government Manufacturing 52

Pharmaceutical Technology

FEBRUARY 13, 2023

As well as presenting an acceptable PK profile and demonstrating in-vivo efficacy, it becomes important to show that the candidate drug has a good safety pharmacology margin with an acceptable drug-drug interaction (DDI) profile.

Food and Drug Administration 52

Food and Drug Administration Leads Pharmaceutical Pharmaceutical research 52

Quantified

JUNE 28, 2022

Having a flawless technical grasp of the medicine is no longer sufficient. Equally, certification can support compliance, fair balance and consistent inclusion of important safety information. Mark holds degrees in Medicine and Pharmacology from the University of Manchester and studied business at Manchester Business School.

Sales 52

Sales Pharma Training Management 52

Pharmaceutical Technology

AUGUST 8, 2022

You want to use it to show what is working well, or tell ‘if you’re struggling in this situation, I want to identify the trigger,’” says Dr. Jose Castillo-Mancilla, associate professor, School of Medicine, University of Colorado, Anschutz. But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors.

Food and Drug Administration 122

Food and Drug Administration FDA Patients Medicine 122

Clarivate

OCTOBER 7, 2024

Back in December 2022, President Biden signed a new law stating that novel medicines no longer needed to be tested on animals to receive U.S. They became integral to physiological and pharmacological research during the 19th century and started to be systematically used for drug development during the 20th century. Works cited Anon.,

Food and Drug Administration 52

Food and Drug Administration Pharmacology Food Engineering 52

Pharmaceutical Technology

OCTOBER 10, 2022

Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options. To say two is fine and enough does a disservice to women,” states Sheryl Kingsberg, PhD, Chief of the Division of Behavioral Medicine at the University Hospitals Cleveland.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

FEBRUARY 17, 2023

In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The clinical pharmacology knowledge also isn’t present at smaller companies, he adds.

FDA 115

FDA Side effects Pharmacology Patients 115

European Pharmaceutical Review

NOVEMBER 13, 2024

New clinical trial findings show that twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP) had high efficacy and safety in a diverse group of participants. This data provides the first in-depth insight into full results of Gilead Sciences pivotal Phase III PURPOSE 2 trial.

Food and Drug Administration 98

Food and Drug Administration Pharmacology Medicine Food 98